Published on 11 Oct 2021 on Zacks via Yahoo Finance
Share of Accolade, Inc. ACCD gained 4.3% after the company reported second quarter fiscal 2021 loss of $0.43 per share, lower than the Zacks Consensus Estimate of a loss of $0.45. ChemoCentryx, Inc.’s CCXI shares surged 96% after the company announced that the Food and Drug Administration has given approval to its Anca-associated vasculitis therapy.Shares of Allogene Therapeutics, Inc. ALLO plummeted 46.1% after the Food and Drug Administration put a hold on its cancer drug trials after chromosomal abnormality was detected in a single patient.Shares of Walmart, Inc. WMT advanced 0.3% after the retailer announced it holiday season plans that include the launch of a direct-to-home wine delivery service.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Walmart Inc. (WMT) : Free Stock Analysis Report ChemoCentryx, Inc. (CCXI) : Free Stock Analysis Report Allogene Therapeutics, Inc. (ALLO) : Free Stock Analysis Report Accolade, Inc. (ACCD) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research